3.1 Viable Airborne Microbial Monitoring

Principles of Active Volumetric Air Sampling

Viable airborne monitoring is a fundamental component of the environmental quality assurance program in sterile compounding. While non-viable particle counters detect total particulate burden, viable air sampling specifically detects and enumerates living microorganisms (bacteria and fungi) suspended in the air. The revised USP General Chapter <797> explicitly mandates active volumetric air sampling and strictly prohibits the use of passive settling plates (agar plates left open to air) as a primary method for viable air evaluation.

Volumetric Air Sampling Mechanics

Active air samplers draw a measured volume of air through a perforated sieve or slit orifice, accelerating particles so that viable microorganisms impact onto a nutrient agar surface.

• Sample Volume: USP <797> requires an impaction air sampler to collect 1 cubic meter (1,000 liters) of air at each sampled location. USP's FAQ adds that settle plates may not be used instead.
• Impaction Velocity: The sampler's velocity must be calibrated to ensure microbial impaction without shearing, desiccating, or lysing viable microbial cells upon contact with the agar.
• Sampling Locations: Sampling sites must be chosen in every classified area: each ISO Class 5 PEC, plus the ISO Class 7 and 8 rooms. In an SCA, that means the PEC. The SOP must include a diagram of the locations, the sample size, and when samples are taken relative to compounding activity. Samplers must be serviced and calibrated as the manufacturer recommends.

---

Sampling Frequencies & Operational Conditions

Under USP <797> (2023 revision), the minimum frequencies for active viable airborne sampling are legally defined:

---

Growth Media and Incubation Regimens

To ensure recovery of environmental isolates exposed to cleaning agents and cleanroom sanitizers, specific nutrient formulations are required:

1. General Growth Media: Trypticase Soy Agar (TSA) (or Soybean-Casein Digest Medium) is the standard medium for bacterial recovery.
2. Media Quality: For air sampling, USP <797> requires a general microbiological growth medium that supports both bacteria and fungi. The manufacturer's certificate of analysis (COA) must confirm growth promotion, pH and sterilization. Neutralizing additives such as lecithin and polysorbate 80 are required for surface sampling media, because those plates touch disinfectant residue (see 3.3).
3. Fungal Media: Malt Extract Agar (MEA), Sabouraud Dextrose Agar (SDA), or equivalent fungal-selective media are utilized to support mold and yeast growth, particularly in Category 3 suites or facilities with a history of fungal recovery.

Dual-Temperature Incubation Protocol

USP <797> accommodates dual-temperature incubation using TSA to detect both environmental bacteria and fungi:

• First Phase: Incubate at 30°C to 35°C for no less than 48 hours (bacteria, including human-associated Gram-positive cocci).
• Second Phase: Then incubate at 20°C to 25°C for no less than 5 additional days (fungi and slower environmental organisms).
• USP says the higher temperature comes first because starting low can compromise recovery of Gram-positive cocci. To shorten the total time, two media devices may be collected at each location and incubated concurrently: one at 30-35°C for at least 48 hours and the other at 20-25°C for at least 5 days.
• The incubator must be outside the sterile compounding area, and its temperature must be monitored and documented during incubation.

---

Action Levels for Viable Airborne Particles

USP <797> defines specific action levels based on the number of colony-forming units (CFUs) recovered per cubic meter ($1,000\text{ liters}$) of sampled air. Exceeding these thresholds triggers an immediate mandatory investigation.

Microbial Identification and Highly Objectionable Organisms

Numerical counts are only half of environmental surveillance. When an air or surface result exceeds its action level, USP <797> requires an attempt to identify the recovered organisms to the genus level, with a microbiologist's help. Below the action level, identification is not required, but it helps when trending shows a problem.

Many facility SOPs label certain taxa objectionable, a practice carried over from the 2008 chapter, and investigate them even at a single colony ($1\text{ CFU}$) in an ISO Class 5 PEC or ISO Class 7 room. Commonly listed groups include:

• Gram-Negative Bacilli: Organisms such as Pseudomonas aeruginosa, Burkholderia cepacia, Enterobacter cloacae, Klebsiella pneumoniae, and Serratia marcescens. These waterborne environmental bacteria shed lipopolysaccharide (LPS) endotoxins from their outer membranes, which can induce fatal septic shock, pyrogenic reactions, and disseminated intravascular coagulation when administered intravenously.
• Coagulase-Positive Staphylococci: Specifically Staphylococcus aureus, indicating severe human touch contamination, respiratory shedding, or failure of personal garbing and mask integrity.
• Filamentous Molds and Fungi: Genera such as Aspergillus, Penicillium, Cladosporium, Fusarium, and Rhizopus. Fungal spores are resilient to standard sanitizers, indicating potential HVAC filter breaches, water damage, or raw material introduction.
• Yeasts: Such as Candida albicans or Rhodotorula, reflecting human commensal shedding or persistent wet harbourage sites.

Clinical Compounding Scenario: Microbial Recovery in an ISO 5 Workstation

Consider a high-volume sterile compounding pharmacy compounding batch cardioplegia solutions. During semi-annual certification under dynamic operating conditions, active volumetric air sampling within an ISO Class 5 horizontal laminar airflow workstation recovers $2\text{ CFU}/\text{m}^3$ on a TSA impaction plate. Subsequent microbiological analysis identifies both colonies as Burkholderia cepacia, a Gram-negative bacillus.

This finding triggers an immediate, multi-step regulatory response:

1. Immediate Operational Halt: The Designated Person immediately orders all compounding within that specific workstation halted.
2. Product Quarantine and Risk Assessment: All compounded sterile preparations prepared inside the workstation since the last verified passing environmental monitoring cycle are placed into quarantined storage. The clinical pharmacy specialist reviews the beyond-use dates (BUDs) and distribution logs to determine if any units were dispensed to intensive care units.
3. Root Cause Analysis (RCA): The facility investigates potential moisture sources, as Burkholderia thrives in aqueous environments. Technicians inspect sink splash guards, water lines to automated compounding devices, disinfectant dilution systems, and HEPA filter integrity.
4. Sporicidal Decontamination and Re-sampling: The workstation is cleaned, disinfected and treated with a sterile sporicidal disinfectant, then sampled again under dynamic conditions. USP requires the follow-up data to be reviewed to confirm the corrective action worked. Compounding resumes when the Designated Person has reviewed those results and closed the investigation.